Efficacy and safety of camrelizumab combined with chemotherapy (irinotecan combined with platinum) followed by camrelizumab combined with apatinib in the first-line treatment of advanced small cell lung cancer: A phase II study.

被引：0
|
作者：
Ni, Jun
Zhang, Xiaotong
Pan, Ruili
Wang, Hanping
Si, Xiaoyan
Cui, Xiaoxia
Zhang, Li
机构：
[1] Chinese Acad Med Sci Peking Union Med Coll, Peking Union Med Hosp, Dept Pulm & Crit Care Med, Beijing, Peoples R China
[2] Peking Union Med Coll & Chinese Acad Med Sci, Dept Pulm & Crit Care Med, Peking Union Med Coll Hosp, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Dept Resp Med, Peking Union Med Coll Hosp, Beijing, Peoples R China
[4] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing, Peoples R China
[5] Peking Union Med Coll & Chinese Acad Med Sci, Dept Pulm & Crit Care Med, Peking Union Med Coll Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8573
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase Ib/II study to evaluate surufatinib combined with camrelizumab and chemotherapy in the second-line treatment of advanced colorectal cancer: Phase Ib results
    Li, Sheng
    Zhu, Liangjun
    Li, Xiaoyou
    Huang, Jiayuan
    Bao, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] Camrelizumab Plus Apatinib as First-Line Treatment for Advanced Squamous Non-small-Cell Lung Cancer: Updated Survival Results of a Phase 2 Trial
    Qin, B.
    Zhai, J.
    Lu, D.
    Ge, X.
    Mao, Y.
    Sheng, S.
    Hu, Y.
    Wang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S321 - S322
  • [43] The role of nivolumab combined to immunotherapy and/or chemotherapy in the first-line treatment of advanced Non Small Cell Lung Cancer
    Rocco, Danilo
    Della Gravara, Luigi
    Battiloro, Ciro
    Gridelli, Cesare
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (03) : 303 - 309
  • [44] Camrelizumab plus platinum-irinotecan followed by maintenance camrelizumab plus apatinib in untreated extensive-stage small-cell lung cancer: a nonrandomized clinical trial
    Ni, Jun
    Si, Xiaoyan
    Wang, Hanping
    Zhang, Xiaotong
    Zhang, Li
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [45] First-line Treatment With Capecitabine Combined With Irinotecan in Patients With Advanced Colorectal Carcinoma A Phase II Study
    Assy, Nimer
    Basher, Walid
    Chetver, Lika
    Shnaider, Julia
    Zidan, Jamal
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2012, 46 (04) : E27 - E30
  • [46] Camrelizumab combined with SOX regimen in the first-line treatment of unresectable advanced or recurrent gastric cancer: A single-arm, prospective, open clinical study.
    Han, Zhengxiang
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [47] Safety and Efficacy of Camrelizumab Combined with Apatinib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Multicenter Retrospective Study
    Yuan, Guosheng
    Cheng, Xiao
    Li, Qi
    Zang, Mengya
    Huang, Wei
    Fan, Wenzhe
    Wu, Tao
    Ruan, Jian
    Dai, Wencong
    Yu, Wenxuan
    Chen, Mian
    Guo, Yabing
    Hu, Xiaoyun
    Chen, Jinzhang
    ONCOTARGETS AND THERAPY, 2020, 13 : 12683 - 12693
  • [48] Efficacy and Safety of Neoadjuvant Camrelizumab and Apatinib Combined with Chemotherapy in Stage IIIA (N2) NSCLC: A Single Arm, Phase II Trial
    Zhao, L.
    Chen, W.
    Guo, T.
    Huang, Y.
    Zhu, L.
    Chen, S.
    Chen, X.
    Zhang, Y.
    Yang, Y.
    Pan, X.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S53 - S53
  • [49] Evaluation of Efficacy and Safety in First-Line Treatment Methods for Extensive-Stage Small Cell Lung Cancer: A Comprehensive Comparative Study of Chemotherapy, Targeted Therapy Combined With Chemotherapy, and Immunotherapy Combined With Chemotherapy
    Zhang, Tiantian
    Tao, Lu
    Chen, Yufo
    Zhang, Shanshan
    Liu, Yang
    Li, Yumei
    Wang, Rui
    CLINICAL RESPIRATORY JOURNAL, 2024, 18 (08):
  • [50] A PHASE II TRIAL OF WEEKLY DOCETAXEL COMBINED WITH CARBOPLATIN AS FIRST-LINE CHEMOTHERAPY FOR ADVANCED NON-SMALL-CELL LUNG CANCER
    Nong, X.
    Zhang, X.
    Xiong, J.
    Fang, W.
    Zhang, L.
    Zhong, L.
    Chen, J.
    Yu, F.
    Qian, J.
    Deng, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 157 - 157
12345